Dr. Wilson Tsai and Dr. Jason Samarasena discuss how Cellvizio functions as an adjunct tool for gastroenterology and surgery, with demonstrated utility and versatility to address key clinical challenges in diagnosis and treatment.
Click the image or button below to view the recorded webinar.
View Video
Read More
The importance of detecting Barrett’s esophagus early
Barrett’s esophagus (BE), a term that just a few decades ago was relatively unknown or unheard of. Today, if you are one of the 20% in the United States suffering from Gastroesophageal Reflux Disease (GERD) or heartburn, then you may have heard of the term Barrett’s esophagus. What is it? Why is it important to understand it? How can you detect it and treat it?
#mc_embed_signup{backgroun...
Read More
BAY AREA PEOPLE Esophageal Cancer Detection
Co-Director of Thoracic's at John Muir, Dr. Wilson Tsai, demonstrates the new technology that could find esophageal cancer sooner
Source: BAY AREA PEOPLE Esophageal Cancer Detection as seen on KTVU Fox 2
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName...
Read More
Cellvizio® Endorsed by the American Society of General Surgeons as Integral to the Care of Patients with Gastroesophageal Reflux Disease (GERD) and Barrett’s Esophagus
PARIS and CAMBRIDGE, Massachusetts, September 1, 2016 /PRNewswire/ --
Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced that the American Society of General Surgeons (ASGS) endorsed Cellvizio® as integral to the comprehensive assessment and therapeutic decisions for the treatment of Barrett...
Read More